Abstract:Atherosclerotic intracranial artery stenosis can cause hypoperfusion of brain tissues and embolus formation, causing stroke. Conservative medical treatment seemed to have little effect on the natural history and prevent the stroke attack caused by artery stenosis. The purpose of stent-assisted angioplasty is to reconstruct the damaged vessels: the indications, feasibility, effectiveness, complications and follow-up for this new treatment method are discussed. A series of 32 cases with symptomatic intracranial artery stenosis were accepted from 1998 to 2002. The mean age was 42 yrs (31∼76 yr), male/female ratio=23/9. All patients were refractory to optimal medical therapy. Lesions included 12 middle cerebral arteries (37.5%), six basilar arteries (18.75%), three distal ICAs (9.38%) and 12 intracranial Vas (37.5%). All patients were treated by methods of transluminal stent-assisted angioplasty under general anesthesia. Patients were premedicated with Aspirin (300mg/per day) and Ticlopidine (250mg/per day), this was continued for six weeks after the procedure. Medical history, anamnesis, and treatment protocol were reviewed and evaluated retrospectively, short-term follow-up (2mths ∼ 1 yr) was also obtained. Primary clinical presentations were TIAs (21/32, 65.63%), minor stroke (8/32, 25%) and severe stroke (3/32, 9.38%). 31 cases (96.86%) were successfully implanted with coronary stents within the stenosed vessels; technical success rate was 96.86%. Instant angiographic results showed the stenosed extent had decreased from 72.36%±5.69 to 10.16%±6.94. One vessel ruptured during the procedure, the patient recovered after surgical repair of the ruptured vessel. Clinical follow-up demonstrated symptoms resolved in most patients (30/32, 93.75%) within the follow-up period, two cases with MCA stenosis had TIAs within two months after the procedure. 12 cases accepted angiographic follow-up. Velocities of stented vessels of five cases (5/21, 23.81%) increased compared to instant results, suggesting restenosis, three of them were confirmed by angiography which included two cases with MCA stenosis (figure 3) and one with distal VA, one of the five cases had recurred TIAs. With the newer generation of coronary stent, this technique seemed safe, feasible and effective to prevent stroke attack, but the indication is very important for the technical success. Restenosis remains a common problem as with coronary stenting. Long-term follow-up will be needed.

Cause Analysis and Treatment of Vertebral Artery Stenosis Angioplasty Restenosis

The Long Term Results Of Vertebral Artery Ostium Stenting In A Single Center

Risk factors ofrestenosis in postoperative patients with vertebral artery stenosis treated by endovascular stent implantation

Endovascular Stenting for Treatment of Vertebral Arterial Stenosis

Effects of the Vertebral Artery Ostium/Subclavian Artery Angle on In-Stent Restenosis after Vertebral Artery Ostium Stenting

Using drug-coated balloons for symptomatic vertebral artery origin stenosis: A systematic review and meta-Analysis

A Comparison of Different Endovascular Treatment for Vertebral Artery Origin Stenosis.

Clinical Analysis of Endovascular Stent Placement in 20 Patients with Carotid Artery Stenosis and Vertebral Artery Stenosis

Influence of Vessel Size and Tortuosity on In-Stent Restenosis after Stent Implantation in the Vertebral Artery Ostium.

Stent Fracture and Restenosis after Percutaneous Transluminal Angioplasty and Stenting for Symptomatic Ostial Vertebral/subclavian Artery Stenosis: a Report of 3 Cases and Literature Review

Balloon-expandable stent angioplasty in the treatment of vertebral artery stenosis in the V2 segment

Treatment and Short-Term Follow-up of Symptomatic Atherosclerotic Intracranial Artery Stenosis by Stent-Assisted Angioplasty.

Analysis of risk factors of restenosis after coronary stenting

Arterial occlusions increase the risk of in-stent restenosis after vertebral artery ostium stenting

Stenting of symptomatic vertebral artery ostium stenosis with self-expanding stents.

The Incidence and Risk Factors of In-Stent Restenosis for Vertebrobasilar Artery Stenting

Stenting of vertebral artery origin atherosclerosis in high-risk patients: bare or coated? A single-center consecutive case series

Intraluminal Stent Placement Treats Symptomatic Proximal Vertebral Artery Stenosis

Research of stent fracture in revascularization for symptomatic ostial vertebral artery stenosis

Drug-eluting stent for treatment of symptomatic vertebral artery origin stenosis

Application of drug-eluting stent for the treatment of symptomatic vertebral artery stenosis